ABVC BioPharma Inc
ABVC
|
$1.475
9.26%
8.47%
6.3M
|
Wholesale Trade
(0.0% 1d) (28.6% 1m) (101.8% 1y) (0.0% 2d) (29.8% 3d) (35.0% 7d) (2674.14% volume)
Earnings Calendar: 2022-11-14
Market Cap: $ 15,576,621
https://abvcpharma.com
Sec Filling | Patents | 34 employees
ABVC BioPharma is a clinical-stage biopharmaceutical company focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process at world-famous research institutions (such as Stanford University, University of California at San Francisco, and Cedars-Sinai Medical Center). The company has an active pipeline of six drugs and one medical device (ABV-1701/Vitargus®) under development.
adhd
add to watch list Paper trade email alert is off
Press-releases
AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
ABVC | $1.475 9.26% 8.47% 6.3M
|
Wholesale Trade
|
| O: -1.96%
H: 0.0%
C: 0.0%
life biopharma acquired
ABVC BioPharma Executes a Global Licensing Definitive Agreement for the Treatment of NSCLC, Expecting Aggregate Income of $13.75M and Royalties of up to $12.50M
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
ABVC | $1.475 9.26% 8.47% 6.3M
|
Wholesale Trade
|
| O: 2.68%
H: 3.48%
C: -11.3%
treatment biopharma royalties global for agreement
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
Published: 2024-04-10 (Crawled : 12:30) - globenewswire.com
ABVC | $1.475 9.26% 8.47% 6.3M
|
Wholesale Trade
|
| O: 5.74%
H: 1.55%
C: -11.63%
biopharma royalties global for
ABVC BioPharma Entered into a Global Licensing Deal of Vitargus with Licensing Income of $33.5M and Royalties up to $60M
Published: 2024-03-26 (Crawled : 12:30) - globenewswire.com
ABVC | $1.475 9.26% 8.47% 6.3M
|
Wholesale Trade
|
| O: 33.81%
H: 3.2%
C: -8.9%
vitargus biopharma royalties global deal
AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
Published: 2024-03-21 (Crawled : 12:30) - globenewswire.com
ABVC | $1.475 9.26% 8.47% 6.3M
|
Wholesale Trade
|
| O: -0.54%
H: 3.33%
C: -1.32%
million biopharma
ABVC BioPharma, Inc. CEO Selected as 2024 Top 10 CEO in CEO Insights Asia Magazine
Published: 2024-03-19 (Crawled : 12:30) - globenewswire.com
ABVC | $1.475 9.26% 8.47% 6.3M
|
Wholesale Trade
|
| O: -1.72%
H: 0.0%
C: 0.0%
ceo asia
ABVC BioPharma Reports Annual 2023 Financials and Provides Fiscal Year 2024 First Quarter Business Update
Published: 2024-03-14 (Crawled : 13:30) - globenewswire.com
ABVC | $1.475 9.26% 8.47% 6.3M
|
Wholesale Trade
|
| O: -0.81%
H: 0.0%
C: 0.0%
first business year update biopharma
ABVC's New Horizon for Oncology and Hematology Aims at Cancer Market of Several Hundred Billion Dollars
Published: 2024-02-27 (Crawled : 13:30) - globenewswire.com
ABVC | $1.475 9.26% 8.47% 6.3M
|
Wholesale Trade
|
| O: 0.82%
H: 0.0%
C: 0.0%
cancer market
ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues
Published: 2024-02-15 (Crawled : 13:30) - globenewswire.com
ABVC | $1.475 9.26% 8.47% 6.3M
|
Wholesale Trade
|
| O: -0.4%
H: 0.0%
C: 0.0%
license biopharma royalties agreement
ABVC BioPharma Receives Australian Patent, Valid Until 2040, for Its Treatment of Major Depressive Disorder (MDD)
Published: 2024-02-12 (Crawled : 13:30) - globenewswire.com
ABVC | $1.475 9.26% 8.47% 6.3M
|
Wholesale Trade
|
| O: -0.76%
H: 3.05%
C: 2.29%
treatment biopharma
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Last 48 Hours Insiders Buying
RKT P 347 | $12.55 -0.63% 0.48% 1.7M
|
Finance
|
22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 16000 | $0.685 39.71% 6.6K
|
Utilities
|
20:01
WABC | $47.86 0.21% 0.21% 140K
|
Finance
|
19:30
MNSB P 310 | $15.88 -2.93% -3.02% 46K
|
Finance
|
15:30
TPL P 3 | $589.01 0.2% -0.04% 53K
|
Miscellaneous
|
15:01
ISBA P 966 | $18.0001 1.63% 3.1K
|
Finance and Insurance
|
15:01
MEGI | $12.04 0.5% 0.0% 150K
|
|
00:30
CTRN P 29000 | $22.11 -0.54% -0.54% 65K
|
Retail Trade
|
22:00
CONN | $3.78 2.16% 2.12% 36K
|
Retail Trade
|
21:30
CMTV P 700 | $16.59 17.43% 1K
|
Finance and Insurance
|
18:30
FNB | $13.67 0.29% 0.0% 2.2M
|
Finance
|
17:30
RMCF | $3.54 0.28% 7.1K
|
Consumer Non-Durables
|
20:10